Organon (OGN) Amortizatization of Intangibles (2020 - 2026)

Organon (OGN) posted quarterly Amortizatization of Intangibles of $47.0 million for Q1 2026, down 6.0% year-over-year from $50.0 million in Q1 2025, and down 6.0% on a QoQ basis from $50.0 million in Q4 2025.

Organon (OGN) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Organon (OGN) has reported Amortizatization of Intangibles for 7 consecutive years, with $47.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles fell 6.0% year-over-year to $47.0 million; the TTM figure through Mar 2026 stood at $202.0 million (up 24.69% YoY), while the FY2025 annual figure was $205.0 million, up 41.38% from the prior year.
  • Amortizatization of Intangibles came in at $47.0 million for Q1 2026 at Organon, down from $50.0 million in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $53.0 million in Q2 2025, with the low at $28.0 million in Q1 2022.
  • Average Amortizatization of Intangibles over 5 years is $37.0 million, with a median of $33.0 million recorded in 2024.
  • Across the five-year window, Amortizatization of Intangibles declined 17.65% in 2022 and surged 55.88% in 2025, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $28.0 million in 2022, then changed by 0.0% to $28.0 million in 2023, then jumped by 53.57% to $43.0 million in 2024, then gained by 16.28% to $50.0 million in 2025, then fell by 6.0% to $47.0 million in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $47.0 million, $50.0 million, and $52.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 1.70 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 931.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 596.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn 47.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 47.00 Mn
Mar 31, 2026 47.00 Mn
Dec 31, 2025 50.00 Mn
Dec 31, 2025 50.00 Mn
Sep 30, 2025 52.00 Mn
Sep 30, 2025 52.00 Mn
Jun 30, 2025 53.00 Mn
Jun 30, 2025 53.00 Mn
Mar 31, 2025 50.00 Mn
Mar 31, 2025 50.00 Mn
Dec 31, 2024 43.00 Mn
Dec 31, 2024 43.00 Mn
Sep 30, 2024 35.00 Mn
Sep 30, 2024 35.00 Mn
Jun 30, 2024 34.00 Mn
Jun 30, 2024 34.00 Mn
Mar 31, 2024 33.00 Mn
Mar 31, 2024 33.00 Mn
Dec 31, 2023 28.00 Mn
Dec 31, 2023 28.00 Mn